B-form DNA minor groove (DNA minor groove)

The B-form DNA minor groove in Clostridioides difficile is a specific structural region of the bacterial genome targeted by a novel class of antibiotics called minor groove binders (MGBs). In the B-DNA conformation, the minor groove is a narrow furrow that provides a unique environment for small molecules to bind via van der Waals forces, hydrogen bonding, and electrostatic interactions, particularly at AT-rich sequences (Hussain et al., 2016, Journal of Antimicrobial Chemotherapy). Binding of therapeutic agents like MGB-BP-3 to this groove displaces essential DNA-binding proteins and inhibits the activity of enzymes such as RNA polymerase and DNA polymerase, leading to the cessation of transcription and replication (MGB Biopharma, 2024). This target is highly relevant in the treatment of Clostridioides difficile infection (CDI), a severe gastrointestinal disease characterized by toxin-mediated diarrhea and inflammation (CDC, 2023). Unlike many traditional antibiotics that target the cell wall or protein synthesis, minor groove binders offer a distinct mechanism of action that can bypass existing resistance mechanisms in Gram-positive bacteria (PubMed, 2020). Current clinical efforts focus on utilizing this target to provide rapid bactericidal activity and reduce the rate of disease recurrence, which is a significant challenge in CDI management (ClinicalTrials.gov, 2021).

Other names

Minor groove of B-DNAB-DNA minor grooveDNA minor groove

Binds to the minor groove of AT-rich regions of bacterial B-form DNA, interfering with the binding of essential proteins and enzymes required for transcription and replication, thereby inhibiting bacterial growth and causing cell death.